ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,860, issued on July 21, was assigned to HUAHUI HEALTH LTD. (Beijing) and NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (Beijing).

"Soluble ACE2 protein, fusion proteins thereof with an FC domain, and methods of treatment of an ACE2-related disease" was invented by Wenhui Li (Beijing), Yonghe Qi (Beijing), Jianhe Chen (Beijing), Jianhua Sui (Beijing), Juan Liu (Beijing), Fengfeng Mao (Beijing) and Ximing Liu (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "A soluble ACE2 and a truncated form thereof, a fusion protein thereof and preparation methods therefor. A soluble ACE2 and a truncated form thereof, as well as a use of the fusion prote...